Among BRCA2 carriers, 10 out of 58 (17.2%) affected with BC had the RAD51-135c allele, compared with one out of 28 (3.6%) of the unaffected carriers (OC cases included; Table 2). This evidence concerns the gene BRCA2 and breast cancer.